IP Library › Granted Patent US 11,719,689
Granted Patent B2
US 11,719,689 · App. 16/639,091 · Granted Aug 8, 2023

Composition for separating blood serum or blood plasma, blood collection container, and method for separating blood serum or blood plasma

Inventors: Ryusuke Okamoto (Tokyo, JP); Kuniya Komai (Shunan, JP)
Assignee: SEKISUI MEDICAL CO., LTD.
G01N33/491A61J1/1468B01D21/262G01N1/28B01D2221/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,719,689
App. No.
16/639,091
Granted
Aug 8, 2023
Kind
B2
Abstract

There is provided a composition for separating blood serum or blood plasma that can inhibit bubbling during sterilization, and can inhibit the occurrence of phase separation during storage. The composition for separating blood serum or blood plasma according to the present invention comprises a (meth)acrylic acid ester-based polymer, a silica fine powder, and a silicone oil, wherein the (meth)acrylic acid ester-based polymer has fluidity at room temperature, and has a weight average molecular weight of 15000 or more and 100000 or less.

Claims (36)

1. A composition for separating blood plasma comprising:

a (meth)acrylic acid ester-based polymer, a silica fine powder, and a silicone oil, wherein

the (meth)acrylic acid ester-based polymer has fluidity at room temperature, and has a weight average molecular weight of 15000 or more and 100000 or less,

a content of the silicone oil is 0.10% by weight or more and 2.00% by weight or less,

the composition for separating blood plasma separates white blood cell-containing blood plasma from blood, and

the composition for separating blood plasma has a specific gravity at 25° C. of greater than 1.060 and 1.095 or less.

2. The composition for separating blood plasma according to claim 1 , wherein the silicone oil is a polyether-modified polyalkylsiloxane.

3. The composition for separating blood plasma according to claim 1 , wherein the silicone oil has an HLB value of 1 or more and 10 or less.

4. The composition for separating blood plasma according to claim 1 , wherein the silica fine powder comprises hydrophilic silica.

5. The composition for separating blood plasma according to claim 4 , wherein a content of the hydrophilic silica is 0.3% by weight or more and 2.20% by weight or less.

6. The composition for separating blood plasma according to claim 4 , wherein the silica fine powder comprises hydrophilic silica and hydrophobic silica.

7. The composition for separating blood plasma according to claim 6 , wherein a total content of the hydrophilic silica and the hydrophobic silica is 1.40% by weight or more and 4.0% by weight or less.

8. The composition for separating blood plasma according to claim 1 , wherein the composition comprises an inorganic powder different from the silica fine powder.

9. The composition for separating blood plasma according to claim 1 , wherein the composition has a specific gravity at 25° C. of 1.068 or more and 1.095 or less.

10. A blood collection container comprising:

a blood collection container body; and

the composition for separating blood plasma according to claim 1 , wherein

the composition for separating blood plasma is housed in the blood collection container body.

11. A method for separating blood plasma using the blood collection container according to claim 10 , comprising the steps of:

collecting blood into the blood collection container body; and

centrifuging the blood collection container in which the blood has been collected.

12. The composition for separating blood plasma according to claim 1 , wherein the (meth)acrylic acid ester-based polymer comprises at least one selected from the group consisting of (meth)acrylic acid alkoxyalkyl esters, (meth)acrylic acid hydroxyalkyl esters, (meth)acrylic acid glycidyl esters, (meth)acrylic acid dialkylaminoalkyl esters, (meth)acrylic acid benzyl esters, (meth)acrylic acid phenoxyalkyl esters, (meth)acrylic acid cyclohexyl esters, (meth)acrylic acid isobornyl esters, and (meth)acrylic acid alkoxysilylalkyl esters.

13. The composition for separating blood plasma according to claim 1 , further comprising two or more colorants.

14. A composition for separating blood plasma comprising:

a (meth)acrylic acid ester-based polymer, a silica fine powder, and a silicone oil, wherein

the (meth)acrylic acid ester-based polymer has fluidity at room temperature, and has a weight average molecular weight of 15000 or more and 100000 or less,

a content of the silicone oil is 0.10% by weight or more and 2.00% by weight or less,

the composition for separating blood plasma separates mononuclear cell-containing blood plasma from blood, and

the composition has a specific gravity at 25° C. of greater than 1.060 and 1.085 or less.

15. A blood collection container comprising:

a blood collection container body; and

the composition for separating blood plasma according to claim 14 , wherein

the composition for separating blood plasma is housed in the blood collection container body.

16. A method for separating blood plasma using the blood collection container according to claim 15 , comprising the steps of:

collecting blood into the blood collection container body; and

centrifuging the blood collection container in which the blood has been collected.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2023
From: TOKUYAMA SEKISUI CO., LTD.
To: SEKISUI MEDICAL CO., LTD.
Reel/Frame 063912/0245 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2020
From: OKAMOTO, RYUSUKE; KOMAI, KUNIYA
To: SEKISUI MEDICAL CO., LTD.; TOKUYAMA SEKISUI CO., LTD.
Reel/Frame 051817/0426 →
Priority Claims (1)
JP 2017-251269 · Dec 27, 2017 · national
Continuity (1)
Related Publication 20200209215A1 · Jul 2, 2020